DOD Multiple Sclerosis Clinical Trial Award


Funding Opportunity ID: 333436
Opportunity Number: W81XWH-21-MSRP-CTA
Opportunity Title: DOD Multiple Sclerosis Clinical Trial Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 12.420
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code: DOD-AMRAA
Agency Name: Department of Defense
Dept. of the Army — USAMRAA
Posted Date: May 10, 2021
Close Date: Oct 01, 2021
Last Updated Date: May 10, 2021
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding: $8,000,000
Expected Number of Awards: 3
Description: The MSRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0), to demonstrate feasibility or inform the design of more advanced trials, through larger-scale phase 1 or phase 2 trials to determine safety or efficacy in relevant patient populations.
Version: 1

Visit the Official Webpage For More Details on DOD Multiple Sclerosis Clinical Trial Award


Please enter your comment!
Please enter your name here